Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio. Filtz A, Gulati M. Prog Cardiovasc Dis 2025 Mar 22:S0033-0620(25)00038.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Filtz A, Gulati M. Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio. Prog Cardiovasc Dis 2025 Mar 22:S0033-0620(25)00038.
PMID: 40122438